1932

Abstract

A key factor in the success of gene therapy is the development of gene delivery systems that are capable of efficient gene transfer in a broad variety of tissues, without causing any pathogenic effect. Currently, viral vectors based on many different viruses have been developed, and their performance and pathogenicity has been evaluated in animal models. The results of these studies form the basis for the first clinical trials for correcting genetic disorders using retroviral, adenoviral, and adeno-associated viral vectors. Even though the results of these trials are encouraging, vector development is still required to improve and refine future treatment of hereditary disorders.

Keyword(s): AAVadenovirusHSVlentivirusretrovirus
Loading

Article metrics loading...

/content/journals/10.1146/annurev.pharmtox.43.100901.140257
2003-04-01
2024-06-20
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.pharmtox.43.100901.140257
Loading
/content/journals/10.1146/annurev.pharmtox.43.100901.140257
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error